Stocklytics Platform
Asset logo for symbol PRCT
PROCEPT BioRobotics Corporation
PRCT73
$54.42arrow_drop_up1.86%$0.99
High Growth
Asset logo for symbol PRCT
PRCT73

$54.42

arrow_drop_up1.86%
Key Stats
Open$53.61
Prev. Close$53.43
EPS-1.75
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range53.61
54.42
52 Week Range24.83
106.40
Ratios
EPS-1.75
Fundamentals
Total Debt-
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

PRCT-
US Healthcare Sector-
US Market-
check_circle

PRCT / Market

PRCT exceeded the US Market which returned -1.56% over the last twenty four hours.
warning

PRCT / Healthcare Sector

PRCT lose to the US Healthcare sector which returned 2.39% over the last twenty four hours.

PROCEPT BioRobotics Corporation (PRCT) Statistics

PROCEPT BioRobotics Corporation (PRCT) is a company specializing in the development and commercialization of robotic surgical systems. As a leader in the field of robotic-assisted surgery, PROCEPT's innovative technology has the potential to revolutionize the way surgical procedures are performed. The company's flagship product, the AquaBeam(R) System, is a minimally invasive surgical platform designed to treat patients with prostate disease.
When it comes to valuation metrics, PROCEPT BioRobotics Corporation has shown promising results. With a market capitalization of over $1 billion, the company has demonstrated strong growth potential. Additionally, PROCEPT's price-to-earnings ratio of 35.6 indicates that investors are willing to pay a premium for the company's future earnings potential. The company's price-to-sales ratio of 11.2 also suggests that investors see the company as a good investment opportunity.
add PROCEPT BioRobotics Corporation to watchlist

Keep an eye on PROCEPT BioRobotics Corporation

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has PROCEPT BioRobotics Corporation (PRCT) stock's performance compared to its sector and the market over the past year?

Over the past year, PROCEPT BioRobotics Corporation (PRCT) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 18.04%, PROCEPT BioRobotics Corporation has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 34.37%, it has fallen short of the market average. This comparison highlights PROCEPT BioRobotics Corporation's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of PROCEPT BioRobotics Corporation (PRCT) stock?

The PE ratio for PROCEPT BioRobotics Corporation (PRCT) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of PROCEPT BioRobotics Corporation (PRCT) stock?

The Earnings Per Share (EPS) for PROCEPT BioRobotics Corporation (PRCT), calculated on a diluted basis, is -$1.75. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of PROCEPT BioRobotics Corporation (PRCT) stock?

The operating margin for PROCEPT BioRobotics Corporation (PRCT) is -28.89%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of PROCEPT BioRobotics Corporation (PRCT) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of PROCEPT BioRobotics Corporation (PRCT) is -$91.38M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does PROCEPT BioRobotics Corporation (PRCT) have?

The total debt for PROCEPT BioRobotics Corporation (PRCT) is currently not available. The net debt for PROCEPT BioRobotics Corporation (PRCT) is currently not available.

Take Your Investments to a Whole New Level